Literature DB >> 25850551

Lung cancer: Implementing lung-cancer screening--oncological 'grey areas'.

Vivek Verma1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25850551     DOI: 10.1038/nrclinonc.2015.65

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  8 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Authors:  Robert Timmerman; Ronald McGarry; Constantin Yiannoutsos; Lech Papiez; Kathy Tudor; Jill DeLuca; Marvene Ewing; Ramzi Abdulrahman; Colleen DesRosiers; Mark Williams; James Fletcher
Journal:  J Clin Oncol       Date:  2006-10-20       Impact factor: 44.544

3.  Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Authors:  Frank J Lagerwaard; Naomi E Verstegen; Cornelis J A Haasbeek; Ben J Slotman; Marinus A Paul; Egbert F Smit; Suresh Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-19       Impact factor: 7.038

4.  Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.

Authors:  Gaurav Marwaha; Kevin L Stephans; Neil M Woody; Chandana A Reddy; Gregory M M Videtic
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.

Authors:  David Palma; Otto Visser; Frank J Lagerwaard; Jose Belderbos; Ben Slotman; Suresh Senan
Journal:  Radiother Oncol       Date:  2011-07-19       Impact factor: 6.280

7.  Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery?

Authors:  Hiroshi Onishi; Hiroki Shirato; Yasushi Nagata; Masahiro Hiraoka; Masaharu Fujino; Kotaro Gomi; Katsuyuki Karasawa; Kazushige Hayakawa; Yuzuru Niibe; Yoshihiro Takai; Tomoki Kimura; Atsuya Takeda; Atsushi Ouchi; Masato Hareyama; Masaki Kokubo; Takuyo Kozuka; Takuro Arimoto; Ryusuke Hara; Jun Itami; Tsutomu Araki
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

8.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.

Authors:  Inga S Grills; Victor S Mangona; Robert Welsh; Gary Chmielewski; Erika McInerney; Shannon Martin; Jennifer Wloch; Hong Ye; Larry L Kestin
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

  8 in total
  7 in total

1.  Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis.

Authors:  Vivek Verma; Charles B Simone; Pamela K Allen; Steven H Lin
Journal:  Clin Lung Cancer       Date:  2017-03-16       Impact factor: 4.785

2.  Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.

Authors:  Michael J Baine; Richard Sleightholm; Beth K Neilsen; David Oupický; Lynette M Smith; Vivek Verma; Chi Lin
Journal:  J Natl Compr Canc Netw       Date:  2019-05-01       Impact factor: 11.908

Review 3.  Relationship and interactions of curcumin with radiation therapy.

Authors:  Vivek Verma
Journal:  World J Clin Oncol       Date:  2016-06-10

4.  Effects of X-radiation on lung cancer cells: the interplay between oxidative stress and P53 levels.

Authors:  Fernando Mendes; Tiago Sales; Cátia Domingues; Susann Schugk; Ana Margarida Abrantes; Ana Cristina Gonçalves; Ricardo Teixo; Rita Silva; João Casalta-Lopes; Clara Rocha; Mafalda Laranjo; Paulo César Simões; Ana Bela Sarmento Ribeiro; Maria Filomena Botelho; Manuel Santos Rosa
Journal:  Med Oncol       Date:  2015-11-18       Impact factor: 3.064

5.  Target migration from re-inflation of adjacent atelectasis during lung stereotactic body radiotherapy.

Authors:  Bijing Mao; Vivek Verma; Dandan Zheng; Xiaofeng Zhu; Nathan R Bennion; Abhijeet R Bhirud; Maria A Poole; Weining Zhen
Journal:  World J Clin Oncol       Date:  2017-06-10

6.  Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer.

Authors:  Vivek Verma; Charles B Simone; Weining Zhen
Journal:  Oncologist       Date:  2016-01-13

Review 7.  Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.

Authors:  Vivek Verma; Charles B Simone; Maria Werner-Wasik
Journal:  Cancers (Basel)       Date:  2017-09-08       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.